These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 32466129

  • 1. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG.
    Cells; 2020 May 25; 9(5):. PubMed ID: 32466129
    [Abstract] [Full Text] [Related]

  • 2. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M, Udi Y, Solomonov I, Sagi I.
    Biochim Biophys Acta Mol Cell Res; 2017 Nov 25; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS, Auf dem Keller U.
    Int J Mol Sci; 2020 Apr 12; 21(8):. PubMed ID: 32290531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
    Rashid ZA, Bardaweel SK.
    Int J Mol Sci; 2023 Jul 28; 24(15):. PubMed ID: 37569509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF, Ricke WA, Bakke LJ, Dow MP, Smith GW.
    Mol Cell Endocrinol; 2002 May 31; 191(1):45-56. PubMed ID: 12044918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression.
    Jhilta A, Jadhav K, Singh R, Ray E, Kumar A, Singh AK, Verma RK.
    ACS Infect Dis; 2024 Aug 09; 10(8):2567-2583. PubMed ID: 39038212
    [Abstract] [Full Text] [Related]

  • 14. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
    Gargiulo S, Gamba P, Poli G, Leonarduzzi G.
    Curr Pharm Des; 2014 Aug 09; 20(18):2993-3018. PubMed ID: 24079771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S, Tandon C, Tandon S.
    Curr Med Chem; 2018 Aug 09; 25(15):1805-1816. PubMed ID: 29210632
    [Abstract] [Full Text] [Related]

  • 20. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W, Saji S, Sato F, Noda M, Toi M.
    Int J Biol Markers; 2013 Jun 28; 28(2):117-30. PubMed ID: 23787494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.